Optune (Tumor Therapy Area) in the clinical Routine for the Treatment of Glioblastoma Patients in Radiation Therapy in Stendal

被引：0
|
作者：
Weinstrauch, E. [1 ]
Lohm, G. [1 ]
机构：
[1] Johanniter Krankenhaus Stendal, Klin Radioonkol & Strahlentherapie, Stendal, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2019年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P02-9
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [11] The Potential Impact of Delayed Radiation Therapy on Patients with Glioblastoma
    Alnaami, Ibrahim
    VanderPluym, Juliana
    Murtha, Albert
    Walling, Simon
    Mehta, Vivek
    Gourishankar, Sita
    Senthilselvan, Ambikaipakan
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2013, 40 (06) : 790 - 794
  • [12] TREATMENT DECISION AND QUALITY OF LIFE OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA RECEIVING TUMOR TREATING FIELDS (TTFIELDS) THERAPY IN ROUTINE CLINICAL CARE: RESULTS FROM THE TIGER STUDY
    Baehr, Oliver
    Tabatabai, Ghazaleh
    Fietkau, Rainer
    Goldbrunner, Roland
    Glas, Martin
    NEURO-ONCOLOGY, 2023, 25
  • [13] Personalized radiation therapy for glioblastoma
    Haque, Waqar
    Butler, E. Brian
    Teh, Bin S.
    CHINESE CLINICAL ONCOLOGY, 2024, 13 (01)
  • [14] A Generative Model for Segmentation of Tumor and Organs-at-Risk for Radiation Therapy Planning of Glioblastoma Patients
    Agn, Mikael
    Law, Ian
    af Rosenscold, Per Munck
    Van Leemput, Koen
    MEDICAL IMAGING 2016: IMAGE PROCESSING, 2016, 9784
  • [15] Dosimetric impact of a Tumor Treating Fields Device for glioblastoma Patients Undergoing simultaneous radiation Therapy
    Li, Taoran
    Shukla, Gaurav
    Peng, Cheng
    Lockamy, Virginia
    Liu, Haisong
    Shi, Wenyin
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [16] Hypofractionated radiation therapy in patients with glioblastoma multiforme: Results of treatment and impact of prognostic factors
    Slotman, BJ
    Kralendonk, JH
    vanAlphen, HAM
    Kamphorst, W
    Karim, ABMF
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 34 (04): : 895 - 898
  • [17] Intensity Modulated Radiation Therapy Versus Volumetric Arc Radiation Therapy in the Treatment of Glioblastoma-Does Clinical Benefit Follow Dosimetric Advantage?
    Sheu, Tommy
    Briere, Tina M.
    Olanrewaju, Adenike M.
    McAleer, Mary Frances
    ADVANCES IN RADIATION ONCOLOGY, 2019, 4 (01) : 50 - 56
  • [18] RADIATION THERAPY REPROGRAMS THE TUMOR METABOLISM TO PROMOTE SURVIVAL AND IMMUNOSUPPRESSION IN GLIOBLASTOMA
    De Martino, Mara
    Daviaud, Camille
    Vanpouille-Box, Claire
    NEURO-ONCOLOGY, 2020, 22 : 218 - 219
  • [19] Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients
    Nicole E. Marshall
    Karla V. Ballman
    John C. Michalak
    Paula J. Schomberg
    Gary V. Burton
    Howard M. Sandler
    Terrence L. Cascino
    Kurt A. Jaeckle
    Jan C. Buckner
    Journal of Neuro-Oncology, 2006, 77 : 315 - 320
  • [20] Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients
    Marshall, Nicole E.
    Ballman, Karla V.
    Michalak, John C.
    Schomberg, Paula J.
    Burton, Gary V.
    Sandler, Howard M.
    Cascino, Terrence L.
    Jaeckle, Kurt A.
    Buckner, Jan C.
    JOURNAL OF NEURO-ONCOLOGY, 2006, 77 (03) : 315 - 320
12345